MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunome (IMNM) Ownership - Who owns Immunome?
Immunome Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
793.99M
P/E Ratio
N/A
Total Cash
217.3M
Projected Growth
N/A
Total Debt
4.83M
Revenue
9.04M
Risk (Beta)
3.20
Dividend Yield
N/A
Total Cash/Share
2.50
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price
Fundamentals
IMNM
Capitalization
794M
P/E Ratio
N/A
Risk (Beta)
3.20
Dividend Yield
N/A
Total Cash
217M
Total Cash/Share
2.50
Total Debt
4.83M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.17%
Revenue
9.04M
ROE
N/A
Book Value
181M
P/B Ratio
2.59
Cash Flow
N/A
Earnings
-5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
4.08
Current Revenue Per Employee
23203.39
Dividends Per Share - Security
N/A
EBITDA
-151.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-150.71
Shares Held By Institutions
778M
Shares Outstanding - Current
87M
Total Liabilities
59.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.738
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com